Crystal Kay Sein-Lwin

Title: Crystal Kay Sein-Lwin: Innovator in Vascular Treatment Devices

Introduction

Crystal Kay Sein-Lwin is a notable inventor based in Hayward, California, recognized for her contributions to medical device technology. With a total of four patents to her name, she has made significant advancements in the treatment of vascular disorders, particularly through innovative embolic devices.

Latest Patents

Among her latest inventions, Crystal has developed an embolic device with improved neck coverage, designed for treating aneurysms and other vascular disorders. This device features a unique spiral-shaped structure that enhances filling and neck blockage beyond conventional options. Notably, the device can also be fashioned into an infinity shape, with multiple configurations that allow independent movement of attached components within a vascular environment.

Another significant patent from Crystal is related to devices and methods for delivering an implant to a vascular disorder. Her invention includes a sophisticated delivery system comprising a delivery pusher, a moveable element, and elongate members that work in unison to release the implant precisely when needed. This advancement holds promise for improving outcomes in vascular treatments.

Career Highlights

Crystal currently works with Incumedx Inc., a company dedicated to advancing innovative medical solutions. Her work is marked by her dedication to improving patient care through engineering creativity and a profound understanding of vascular mechanics.

Collaborations

Throughout her career, Crystal has collaborated with talented professionals, including her coworkers Amiel Richard Aguilar and Nga Doan. Together, they contribute to a dynamic team focused on creating cutting-edge medical devices.

Conclusion

Crystal Kay Sein-Lwin stands out as an inventor committed to revolutionizing medical treatments for vascular disorders. With her impressive portfolio of patents and collaborative spirit, she continues to drive innovation within the field, offering hope for enhanced patient care and improved treatment options.